About us
Recognizing our role in contributing
to a sustainable health care system,
we continue to perform our activities and services.
価値を証明し、
その価値を向上させていく
Recognizing our role in contributing
to a sustainable health care system,
we continue to perform our activities and services.
We provide appropriate solutions and offer consulting services, based on databases in each of the fields of medical drugs, veterinary drugs, agricultural chemicals, and in-vitro diagnostics.
An interview with our President and CEO, Hitoshi Kimura, has been published on the official website of theHealthcare Venture Award hosted by Keio University, an event sponsored by our company.(“Doing What Is Truly Good for Healthcare and Society” — The Spirit Upheld Since Our Founding and theMilestones Crecon Research & Consulting Envisions for the Future of Society)
Hitoshi Kimura, President and CEO served as the guest speaker for a Special Lecture at the 58th Tokai Pharmaceutical Conference (December 7, 2025), hosted by the Aichi Pharmaceutical Association.(The 58th Tokai Pharmaceutical Conference, Special Lecture: “Issues and Outlook for Japan’s Pharmaceutical Supply from an International Perspective”)
Hitoshi Kimura, President and CEO, served as a guest speaker for an educational lecture at the Joint Academic Congress of Three Societies (October 18-19, 2025). The congress was held by the Japanese Society of Oral Therapeutics and Pharmacology, the Japan Dental Society of Oriental Medicine, and the Japanese Association for Oral Infectious Diseases.(October 19, 2025, Educational Lecture 2 at the Joint Academic Congress of Three Societies: “Fundamental Causes of Pharmaceutical Supply Shortages and the Challenge of Ensuring Stable Supply in Japan”)
An article of a guest lecture by Hitoshi Kimura, President and CEO, was published in the September issue of the Journal of Japan Pharmaceutical Wholesalers Association (2025 Vol.49 No.9).(July 17th, 2025, Lecture session at “HILL TOP SEMINAR 2025”: “Changes in the Pharmaceutical Distribution Environment and the Potential of Pharma Wholesalers”)
